Owkin
 | |
| Industry | computer programming  |
|---|---|
| Founded | August 3, 2016 |
| Founder | Gilles Wainrib, Thomas Clozel |
| Headquarters | Paris , France |
Area served | US, France, UK, Switzerland |
| Products | Owkin Platform |
Number of employees | 172 (2022) |
| Website | owkin |
Owkin is a medical A.I. company created in 2016[1] that develops a federated learning A.I. platform to help pharmaceutical companies discover new drugs.[2] Owkin has collaborated with Amgen to demonstrate the ability of A.I. to improve cardiovascular prediction.[3]
Company history
Owkin was founded in 2016, by Gilles Wainrib, a professor of Artificial Intelligence, and Thomas Clozel, a clinical research doctor and son of Jean-Paul and Martine Clozel founders of Swiss biotech Actelion.[4]
Fund Raising
- October 30, 2016: The company raises a $2.1 million seed round from friends and family and NJF Capital
- January 16, 2018: The company raises a $11 million series A round with new investors Otium Capital, Cathay Innovation; GV[5]
- May 23, 2018: The company raises a $5 million extension series A round with GV
- March 7, 2019: The company raises a $13 million extension series A round with Eight Roads Venture[6]
- May 7, 2020: The company raises a $35 million extension series A round with MACSF, BPI France
- July 1, 2020: The company raises a $18 million extension series A round with Mubadala Capital Ventures
- November 18, 2021: The company raises a $180 million corporate round with Sanofi
- June 8, 2022: The company raises a $50 million series B round with Bristol Myers Squibb
Valuation
Owkin has raised over $255 million and became a ‘unicorn’ [7] – a startup valued at more than $1 billion – in November 2021 through a $180 million investment from French biopharma company Sanofi.
References
- ^ "OWKIN FRANCE (PARIS 10) Chiffre d'affaires, résultat, bilans sur SOCIETE.COM - 822393591". www.societe.com. Retrieved 2021-12-29.
- ^ Council, Jared (2020-05-11). "Intel, Health Institutions to Use Emerging AI Technique to Improve Tumor Detection". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-12-29.
- ^ "Amgen, Owkin Use AI to Improve Cardiovascular Risk Prediction". Contract Pharma. Retrieved 2021-12-29.
- ^ "Owkin heads to Basel". Basel Area Business & Innovation. Retrieved 2021-12-29.
- ^ "OWKIN Closes $11 Million Series A Financing Round". Cathay Capital. Retrieved 2021-12-29.
- ^ "Owkin - enabling breakthrough medical research". Eight Roads. Retrieved 2021-12-29.
- ^ Rosemain, Mathieu (2021-11-18). "Drugmaker Sanofi invests $180 mln in French AI startup Owkin". Reuters. Retrieved 2021-12-29.